Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01832090 · ClinicalTrials.gov registry record · NA

Evaluation of Radiesse® Dermal Filler for Hand Treatment

A NA study, sponsored by Merz North America.

Completed
Registry status
NA
Development phase
118
Enrollment target

NCT01832090 is a NA study that has completed, run by Merz North America. The registered enrollment target is 118 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01832090, a NA study, has completed, sponsored by Merz North America.

COMPLETED
Registry status
NA
Development phase
118 participants
Enrollment target

Study Summary

The purpose of this study is to assess the safety and effectiveness of Radiesse® Injectable Dermal Filler for hand treatment.

Interventions

  • DEVICE Radiesse® Injectable Dermal Filler

Trial Details

FieldValue
Enrollment Target 118 participants
Start Date 2013-03
Est. Completion 2014-09
Phase NA

Sponsor

Merz North America

35 total trials

What the Registry Record Tells You About NCT01832090

The ClinicalTrials.gov registry entry for NCT01832090 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 118 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Merz North America, which has 35 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Radiesse® Injectable Dermal Filler is the first listed.

NCT01832090 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01832090 about?

NCT01832090 is a clinical study titled "Evaluation of Radiesse® Dermal Filler for Hand Treatment". The purpose of this study is to assess the safety and effectiveness of Radiesse® Injectable Dermal Filler for hand treatment.

What is the current status of trial NCT01832090?

This trial is currently completed. It is a NA study. The enrollment target is 118 participants. The study started on 2013-03. Estimated completion is 2014-09.

What interventions are being tested in trial NCT01832090?

The interventions under investigation include: Radiesse® Injectable Dermal Filler (DEVICE).

Who is sponsoring clinical trial NCT01832090?

This trial is sponsored by Merz North America, which has 35 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.